
1. Technology overview
4DMedical Limited (ASX:4DX) is an Australian respiratory imaging and lung analysis software company, with its head office at 700 Swanston Street, Carlton, Victoria, and a US office in Woodland Hills, California. Its privacy policy names 4DMedical Limited under an Australian ABN and lists related US entities.
CT:VQ is described as a non-contrast ventilation-perfusion imaging solution: it works from CT scans without injected contrast agents, radiotracers or specialized nuclear medicine cameras. The company also offers XV Technology with the XV Scanner for lung function research, plus IQ-UIP for early detection of idiopathic pulmonary fibrosis and other CT-based lung analysis modules.
2. Highlighted features & specifications
- CT:VQ: non-contrast CT-based ventilation-perfusion imaging.
- IQ-UIP: software for early detection of idiopathic pulmonary fibrosis.
- XV Scanner: lung function research scanner within XV Technology.
- CT analysis modules: product list includes LDAf, LDAi, CAC, LVAS, LTA and PHA.
- Partner integrations: 2026 news lists partnerships with RevealDx and Azra AI.
- Regulatory coverage: FDA, CE and TGA status listed for CT:VQ.
3. Potential application
Large Vietnamese hospitals can use CT-based ventilation-perfusion analysis to assess suspected pulmonary embolism when nuclear scans are unavailable. Respiratory centers can use fibrosis detection software to screen interstitial lung disease earlier. Imaging chains can add lung analysis services on existing CT scanners.
4. Benefits
Adds lung function information to a standard CT scan without contrast or radiotracer. Avoids the need for dedicated nuclear medicine infrastructure, according to the company. Holds FDA 510(k) clearance, CE Mark (March 2026) and TGA approval (June 2026) for CT:VQ per company news. Imaging provider SimonMed has launched it in the United States.
5. Market trends & opportunities
Pulmonary embolism and chronic lung disease assessment is moving toward CT-based functional imaging that avoids contrast and radiotracer supply constraints. Vietnamese and Southeast Asian hospitals with CT fleets but limited nuclear medicine capacity could benefit from software-only lung function imaging.
6. Other information
Listed on the ASX as 4DX. Offices in Carlton (Australia) and Woodland Hills (USA). Company news dates: CE Mark 2026-03, acquisition agreement for contextflow 2026-06, TGA approval 2026-06, SimonMed launch 2026-11. Founding year is not stated on the pages fetched.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































